Back
Axon Enterprise 10K Form
Buy
87
AXON
Axon Enterprise
Last Price:
636.58
Seasonality Move:
11.99%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
2020-11-13 | 10Q | AXON/Axon Enterprise Quarterly |
2020-08-11 | 10Q | AXON/Axon Enterprise Quarterly |
2020-06-10 | 10K | AXON/Axon Enterprise Annual |
2020-02-10 | 10Q | AXON/Axon Enterprise Quarterly |
2019-11-08 | 10Q | AXON/Axon Enterprise Quarterly |
2019-08-09 | 10Q | AXON/Axon Enterprise Quarterly |
Receive AXON News And Ratings
See the #1 stock for the next 7 days that we like better than AXON
AXON Financial Statistics
Sales & Book Value
Annual Sales: | $1.56B |
---|---|
Cash Flow: | $64.85M |
Price / Cash Flow: | 223.88 |
Annual Sales: | $27.60 |
Price / Book: | 23.11 |
Profitability
EPS (TTM): | 3.87000 |
---|---|
Net Income (TTM): | $296.55M |
Gross Margin: | $955.38M |
Return on Equity: | 16.51% |
Return on Assets: | 8.21% |
Axon Enterprise Earnings Forecast
Key Axon Enterprise Financial Ratios
- The Gross Profit Margin over the past 24 years for AXON is 61.11%.
- The Selling, General & Administrative Expenses for AXON have been equal to 31.78% of Gross Profit Margin.
- The Research & Development expenses have been 19.43% of Revenue.
- The Interest Expense is 4.01% of Operating Income.
- The Net Earning history of AXON is 11.14% of Total Revenues.
- Per Share Earnings over the last 24 years have been positive in 10 years.
Axon Enterprise Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | NASDAQ |
---|---|
Industry: | Aerospace & Defense |
Sector: | Industrials |
Current Symbol: | AXON |
CUSIP: | G0750W |
Website: | investor.axon.com |
Debt
Debt-to-Equity Ratio: | 0.32 |
---|---|
Current Ratio: | 2.96 |
Quick Ratio: | 2.48 |
Price-to-Earnings
Trailing P/E Ratio: | 275.49 |
---|---|
Forward P/E Ratio: | 101.81 |
AXON Technical Analysis vs Fundamental Analysis
Buy
87
Axon Enterprise (AXON)
is a Buy
Is Axon Enterprise a Buy or a Sell?
-
Axon Enterprise stock is rated a Buy
The current Axon Enterprise [AXON] share price is $636.39. The Score for AXON is 87, which is 74% above its historic median score of 50, and infers lower risk than normal.